First pediatric flu death in Washington state highlights rising cases across the state

Initiate a 2% portfolio position long Quidel/QuidelOrtho (QDEL) via a 60–90 day call spread (buy ATM, sell +10–15% strike) to capture expected testing volume uplift; target realized upside >15% and take profits if shares rise >20% or weekly test orders decline >25%.

Establish a 2.5% long position in CVS Health (CVS) to capture vaccine administration revenue over the next 6–12 weeks; set a hard exit by April 30, 2026 or if same-store vaccination volumes drop below prior-year levels by >10% for two consecutive weeks.

Buy 4–6 week out-of-the-money puts (size = 0.5–1% portfolio risk) on Delta Air Lines (DAL) or United (UAL) as a hedge against travel-demand softness from worsening respiratory outbreaks; tighten/exit if CDC hospitalization growth <5% week-over-week for two weeks.

Initiate a 1% strategic long in GlaxoSmithKline (GSK) or Sanofi (SNY) with 6–12 month horizon to play policy-driven booster demand; add another 1% if state-level pediatric deaths across 3+ states occur within 30 days or if governments announce new bulk procurement.

Monitor two triggers over the next 30 days — (A) national influenza hospitalizations rising >20% week-over-week, (B) three or more pediatric deaths reported in separate states — and increase diagnostic and retail immunizer positions by 50% if either trigger is hit.

AllMind

AllMind

First pediatric flu death in Washington state highlights rising cases across the state

Analysis

AllMind AI Terminal

Market Sentiment

Key Decisions for Investors